X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (32) 32
humans (30) 30
clinical neurology (26) 26
multiple sclerosis (25) 25
neurosciences (18) 18
adult (16) 16
female (16) 16
male (15) 15
middle aged (13) 13
multiple sclerosis - drug therapy (12) 12
neurology (10) 10
treatment outcome (9) 9
double-blind (8) 8
multiple sclerosis, relapsing-remitting - drug therapy (8) 8
cohort studies (7) 7
abridged index medicus (6) 6
dose-response relationship, drug (6) 6
immunology (6) 6
interferon (6) 6
interferon beta-1a (6) 6
interferon-beta - therapeutic use (6) 6
management (6) 6
natalizumab (6) 6
progressive multifocal leukoencephalopathy (6) 6
research (6) 6
risk (6) 6
therapy (6) 6
young adult (6) 6
adjuvants, immunologic - therapeutic use (5) 5
care and treatment (5) 5
clinical trials (5) 5
follow-up studies (5) 5
glatiramer acetate (5) 5
immunologic factors - adverse effects (5) 5
immunosuppressive agents - therapeutic use (5) 5
interferon beta-1b (5) 5
interferon-beta - administration & dosage (5) 5
mri (5) 5
multiple-sclerosis (5) 5
patients (5) 5
placebo-controlled trial (5) 5
randomized controlled trials as topic (5) 5
adolescent (4) 4
aged (4) 4
diagnostic-criteria (4) 4
disease progression (4) 4
drug therapy (4) 4
guidelines (4) 4
immunologic factors - therapeutic use (4) 4
interferon-beta - pharmacology (4) 4
magnetic resonance imaging (4) 4
multicenter (4) 4
nuclear magnetic resonance--nmr (4) 4
prospective studies (4) 4
risk factors (4) 4
surgery (4) 4
t-cells (4) 4
time factors (4) 4
adjuvants, immunologic - adverse effects (3) 3
aged, 80 and over (3) 3
alemtuzumab (3) 3
amyotrophic lateral sclerosis (3) 3
amyotrophic-lateral-sclerosis (3) 3
controlled phase-3 trial (3) 3
disability (3) 3
disability evaluation (3) 3
disease (3) 3
disease-activity (3) 3
drug administration schedule (3) 3
dysphagia (3) 3
efficacy (3) 3
fingolimod (3) 3
gene expression regulation - drug effects (3) 3
immunologic factors - administration & dosage (3) 3
immunosuppressive agents - adverse effects (3) 3
injections, subcutaneous (3) 3
interferon-beta (3) 3
interferon-beta - adverse effects (3) 3
italy (3) 3
lymphocytes (3) 3
medicine & public health (3) 3
medicine, general & internal (3) 3
monoclonal antibodies (3) 3
neurological diseases (3) 3
neuroradiology (3) 3
patient compliance (3) 3
pregnancy (3) 3
prognosis (3) 3
psychiatry (3) 3
recurrence (3) 3
remitting multiple-sclerosis (3) 3
retrospective studies (3) 3
safety (3) 3
adjuvants, immunologic - administration & dosage (2) 2
amyotrophic lateral sclerosis - mortality (2) 2
analysis (2) 2
animals (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Neurology, ISSN 0364-5134, 10/2014, Volume 76, Issue 4, pp. 489 - 508
Objective: To investigate whether a histone deacetylase inhibitor (HDACi) would be effective in an in vitro model for the neurodegenerative disease Friedreich... 
PLURIPOTENT STEM-CELLS | THERAPEUTICS | TRIPLET-REPEAT EXPANSION | FRATAXIN | GENE | CONTRACTION | NICOTINAMIDE | TRANSCRIPTION | DIFFERENTIATION | HISTONE DEACETYLASE INHIBITORS | NEUROSCIENCES | CLINICAL NEUROLOGY | Leukocytes, Mononuclear - metabolism | Area Under Curve | Friedreich Ataxia - pathology | Humans | Middle Aged | Male | Friedreich Ataxia - genetics | Dose-Response Relationship, Drug | Young Adult | Cell Differentiation - genetics | Benzamides - therapeutic use | Pluripotent Stem Cells | Chromatin Immunoprecipitation | Adult | Female | Benzamides - pharmacology | Aminocaproates - therapeutic use | Neurons - drug effects | Membrane Potentials - drug effects | Friedreich Ataxia - drug therapy | Leukocytes, Mononuclear - drug effects | Cross-Sectional Studies | Double-Blind Method | Administration, Oral | Gene Expression Regulation - genetics | Aminocaproates - pharmacology | DNA Methylation - genetics | Membrane Potentials - physiology | Nerve Tissue Proteins - genetics | Gene Expression Regulation - drug effects | Nerve Tissue Proteins - metabolism | Cell Differentiation - drug effects | Adolescent | Trinucleotide Repeat Expansion - genetics | Iron-Binding Proteins - genetics | Histone Deacetylase Inhibitors - therapeutic use | DNA Methylation - drug effects | Cell Line, Transformed | Cohort Studies | Epigenetics | Ataxia | Chromatin | Gene expression | Index Medicus
Journal Article
Journal Article
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 8/2019, Volume 25, Issue 9, pp. 1263 - 1272
Background: With many options now available, first therapy choice is challenging in multiple sclerosis (MS) and depends mainly on neurologist and patient... 
relapsing–remitting | persistence | Switch | naïve | disease modifying therapies | real-life | relapsing-remitting | NATALIZUMAB | NEUROSCIENCES | ADHERENCE | CLINICAL NEUROLOGY | COMORBIDITIES | DRUGS | INJECTIONS | FINGOLIMOD | naive | Intolerance | Spinal cord | Multiple sclerosis | Demography | Copolymer 1 | Nuclear magnetic resonance--NMR | Magnetic resonance imaging | Decision making | Interferon | Patients | Index Medicus
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 04/2007, Volume 7, Issue 4, pp. 535 - 542
At present, two types of recombinant human interferon (IFN)-β are in clinical use. IFN-β 1a is produced in genetically engineered Chinese hamster ovary cells,... 
IFN-β | interferon | interferon-β | multiple sclerosis | Interferon-β | Multiple sclerosis | Interferon
Journal Article
Journal Article
by Wolfe, Gil I and Wolfe, Gil and Kaminski, Henry and Kaminski, Henry J and Aban, Inmaculada B and Aban, Inmaculada and Minisman, Greg and Kuo, Hui-Chien and Marx, Alexander and Ströbel, Philipp and Mazia, Claudio and Oger, Joel and Cea, Gabriel and Cea, J Gabriel and Heckmann, Jeannine M and Heckmann, Jeannine and Evoli, Amelia and Nix, Wilfred and Ciafaloni, Emma and Antonini, Giovanni and Witoonpanich, Rawiphan and King, John and King, John O and Beydoun, Said and Beydoun, Said R and Chalk, Colin and Chalk, Colin H and Barboi, Alexandru C and Barboi, Alexandru and Amato, Anthony A and Amato, Anthony and Shaibani, Aziz I and Shaibani, Aziz and Katirji, Bashar and Lecky, Bryan R F and Lecky, Bryan and Buckley, Camilla and Vincent, Angela and Dias-Tosta, Elza and Yoshikawa, Hiroaki and Waddington-Cruz, Márcia and Pulley, Michael T and Pulley, Michael and Rivner, Michael H and Rivner, Michael and Kostera-Pruszczyk, Anne and Kostera-Pruszczyk, Anna and Pascuzzi, Robert M and Pascuzzi, Robert and Jackson, Carlayne E and Jackson, Carlayne and Verschuuren, Jan and Verschuuren, Jan J G M and Massey, Janice M and Massey, Janice and Kissel, John T and Kissel, John and Werneck, Lineu C and Werneck, Lineu and Benatar, Michael and Barohn, Richard and Barohn, Richard J and Tandan, Rup and Mozaffar, Tahseen and Silvestri, Nicholas J and Conwit, Robin and Sonett, Joshua R and Sonett, Joshua and Jaretzki, Alfred and Newsom-Davis, John and Cutter, Gary and Cutter, Gary R and Feese, Michelle and Saluto, Valeria and Rosenberg, Moises and Alvarez, Valeria and Rey, Lisa and Butzkueven, Helmut and Goldblatt, John and Carey, John and Pollard, John and Reddel, Stephen and Handel, Nicholas and McCaughan, Brian and Pallot, Linda and Novis, Ricardo and Boasquevisque, Carlos and Morato-Fernandez, Rubens and Ximenes, Manoel and Scola, Rosana and Soltoski, Paulo and Moore, Fraser and Mulder, David and Wadup, Lisa and Mezei, Michele and Evans, Kenneth and Jiwa, Theresa and Schaffar, Anne and White, Chris and Toth, Cory and ... and MGTX Study Grp and MGTX Study Group
The Lancet Neurology, ISSN 1474-4422, 03/2019, Volume 18, Issue 3, pp. 259 - 268
The Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone (MGTX) showed that thymectomy combined with prednisone was superior to... 
CLINICAL NEUROLOGY | QUALITY-OF-LIFE | Care and treatment | Prednisone | Corticosteroids | Myasthenia gravis | Analysis | Steroids | Corticoids | Immunoglobulins | Stroke | Patients | Studies | Neurological diseases | Thymectomy | Motivation | Neuromuscular junctions | Myasthenia | Acetylcholine | EMG | Long-term effects
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2016, Volume 2016, Issue 5
This is the protocol for a review and there is no abstract. The objectives are as follows: To estimate the benefit and safety of all DMDs that have been... 
MEDICINE, GENERAL & INTERNAL | ACTIVATION | ORAL CLADRIBINE | GLATIRAMER ACETATE | LAQUINIMOD | THERAPIES | PLACEBO-CONTROLLED TRIAL | DIAGNOSTIC-CRITERIA | IN-DEEP PROJECT | NETWORK METAANALYSIS | INTERFERON BETA-1A
Journal Article
Journal Article
by Lavie, Caroline and Rollot, Fabien and Durand-Dubief, Françoise and Marignier, Romain and Ionescu, Iuliana and Casey, Romain and Moreau, Thibault and Tourniaire, Patricia and Hutchinson, Michael and D’Hooghe, Marie Béatrice and Laplaud, David-Axel and Clavelou, Pierre and De Sèze, Jérôme and Debouverie, Marc and Brassat, David and Pelletier, Jean and Lebrun-Frenay, Christine and Le Page, Emmanuelle and Castelnovo, Giovanni and Berger, Eric and Hautecoeur, Patrick and Heinzlef, Olivier and Durelli, Luca and Clerico, Marinella and Trojano, Maria and Patti, Francesco and Vukusic, Sandra and Alpérovitch, A and Carton, H and d’Hooghe, M.B and Hommes, O and Hutchinson, M and Adeleine, P and Biron, A and Cortinovis-Tourniaire, P and Grimaud, J and Hours, M and Moreau, T and Vukusic, S and Confavreux, C and Chauplannaz, G and Latombe, D and Clanet, M and Lau, G and Rumbach, L and Goas, J.Y and Rouhart, F and Mazingue, A and Roullet, E and Madigand, M and Hautecoeur, P and Brunet, P and Edan, G and Allaire, C and Riffault, G and Leche, J and Benoit, T and Simonin, C and Ziegler, F and Baron, J.C and Rivrain, Y and Dumas, R and Loche, D and Bourrin, J.C and Huttin, B and Delisse, B and Gibert, I and Boulay, C and Verceletto, M and Durand, G and Bonneviot, G and Gil, R and Hedreville, M.A and Belair, C and Poitevin, R.J and Devoize, J.L and Wyremblewski, P and Delestre, F and Setiey, A and Comi, G and Filippi, M and Ghezzi, A and Martinelli, V and Rossi, P and Zaffaroni, M and Tola, M.R and Amato, M.P and Fioretti, C and Meucci, G and Inglese, M and Mancardi, G.L and Gambi, D and Thomas, A and Cavazzuti, M and Citterio, A and Heltberg, A and Hansen, H.J and Fernandez, O and Romero, F and Arbizu, T and ... and PRIMS Investigator and POPARTMUS Investigator and PRIMS and POPARTMUS investigators
Multiple Sclerosis Journal, ISSN 1352-4585, 4/2019, Volume 25, Issue 4, pp. 591 - 600
Background: Obstetrical analgesia remains a matter of controversy because of the fear of neurotoxicity of local anesthetics on demyelinated fibers or their... 
neuraxial analgesia | post-partum | Multiple sclerosis | relapses | pregnancy | GUIDELINES | INTERFERON-BETA EXPOSURE | NEUROSCIENCES | CLINICAL NEUROLOGY | WOMEN | ANESTHESIA | MULTIPLE-SCLEROSIS | PREDICTORS | DIAGNOSTIC-CRITERIA | Pregnancy | Analgesia | Neurotoxicity | Pain perception | Progestin | Data processing | Anesthetics | Estradiol | Local anesthetics | Life Sciences | Santé publique et épidémiologie
Journal Article